5-Bromo-4-methylthiophene-2-carbaldehyde, 98.0%, 100g

3-Methoxy-2,5-dimethylpyrazine, 95.0%, 1g

(4-Bromo-3,5-dimethylphenyl)methanol, 95.0%, 5g

Ethyl 2-(chloromethyl)nicotinate, 95.0%, 250mg

Methyl 2-chloro-4-(furan-2-yl)benzoate, 96%, 250mg

(5-Bromo-6-chloropyridin-2-yl)methanamine hydrochloride, 95.0%, 250mg

2-Fluoro-6-(trifluoromethyl)phenyl isocyanate, 99.0%, 1g

1mol/L NaPF6 EC:DEC (1:1v/v%), 100g

6-(3-methyl-1,2,4-oxadiazol-5-yl)quinoxaline, 95.0%, 500mg

(R)-1-Aminopropan-2-ol, 95.0%, 5g

(R)-6-METHYLMORPHOLIN-3-ONE, 95%, 5g

5,6-Dichloro-N-(2,4-dimethoxybenzyl)-N-(5-fluorothiazol-2-yl)pyridine-3-sulfonamide, 98%, 50mg

Methylhydrosiloxane-Dimethylsiloxane copolymer, Hydride terminated cSt 30-50, 100g